REG - Baillie Gifford US - Directorate Change

Baillie Gifford Us Growth TrustAnnouncement

23/10/2025 10:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251023:nRSW5836Ea&default-theme=true

RNS Number : 5836E  Baillie Gifford US Growth Trust PLC  23 October 2025

Baillie Gifford US Growth Trust plc (USA)

 

Legal Entity Identifier: 213800UM1OUWXZPKE539

 

Appointment of New Director

 

The Board is pleased to announce the appointment of Ms Elizabeth Flockhart as
non-executive Director of the Company with effect from 1 November 2025.

 

Liz Flockhart is an experienced investment professional with over 20 years in
fund management and investment oversight. After qualifying as a chartered
accountant, Liz started her investment career as a fund manager at Martin
Currie plc before moving to Standard Life plc, latterly Aberdeen plc as Global
Head of Oversight. She led a team responsible for the oversight of public
market assets, including investment trusts. Currently, Liz is a Trustee
Director, Chair of Audit and member of the Investment Committee for the
Nuclear Liabilities Fund, a £20 billion trust set aside for decommissioning
costs in the UK.

 

The appointment of Ms Elizabeth Flockhart falls to be ratified by shareholders
at the Annual General Meeting of the Company to be held in September 2026.

 

There is no other information required to be disclosed under UK Listing Rule
6.4.8.

 

Baillie Gifford & Co Limited

Managers and Secretaries

23 October 2025

 

Regulated Information Classification: Additional regulated information
required to be disclosed under the applicable laws and regulations.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAGCBDGSDDDGUX



            Copyright 2019 Regulatory News Service, all rights reserved